Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care
A. C. Garcia, Myla Chistie Araujo Custodio Bonifácio, L. O. Maia
Progress in Palliative Care July 3, 2024 DOI: 10.1080/09699260.2024.2374602 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | End-of-life distress Psychedelic-assisted therapy |
| Key findings | Compassionate care is a vital factor for positive outcomes in psychedelic-assisted therapy within hospice and palliative care. |
Abstract
The scientific community's interest in psychedelic-assisted therapies (PAT) as a potential new therapeutic modality is growing, as evidence suggests that their use has a significant impact on the outcomes of patients with various conditions, including those with serious illnesses. In the context of PAT, the interpersonal bond established between patient and therapist is a vital factor for the positive results of this therapeutic approach. The aim of this article is to discuss the importance of these professionals adopting a compassionate care approach in the context of PAT in hospice and palliative care. This study starts with a brief review of the current literature on the therapeutic potential of PAT for people with serious diseases. Next, the definition of compassion and compassionate care in healthcare will be explored. Based on what the literature points out regarding the essential competencies for psychedelic therapists, it will address how compassionate care can contribute to the application of PAT in the hospice and palliative care context. Finally, the article will present implications for the research and practice of compassionate care in PAT, especially directed at people in hospice and palliative care.
Comparable studies
Other narrative reviews on end-of-life distress, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Palliative care clinicians and patients | 2022 | Review | |
| The Potential of Psychedelics for End of Life and Palliative Care. Patients with life-threatening diagnoses | 2022 | Review | |
| Psilocybin in Palliative Care: An Update. Palliative care patients | 2023 | Review | |
| Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022. People with terminal illnesses experiencing depression, anxiety, or existential distress | 2023 | Scoping review | n = 25 |
| Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application—a review | 2024 | Narrative review |
Citations in the library
Cited by 2
Cites 24
- Developing Guidelines and Competencies for the Training of Psychedelic Therapists Journal of Humanistic Psychology June 29, 2017
- Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress Journal of Humanistic Psychology June 14, 2017
- Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy Transcultural Psychiatry January 26, 2021
- The Psychedelic Mystical Experience in the Human Encounter with Death Harvard Theological Review 1969
- Psychedelics. Current Biology 2022
and 19 more in the library